Is there a place for definitive radiotherapy in the treatment of unresectable soft-tissue sarcoma? A systematic review.

Benoit AllignetMarie-Pierre SunyachXavier Geets Waisse Waissi

Published in: Acta oncologica (Stockholm, Sweden) (2022)

Definitive EBRT with dose 64-66 Gy seems to be a safe and efficient treatment for unresectable STS. Future clinical trials should assess the potential of biomarkers of response, thus identifying patients that could benefit from local treatment.

Keyphrases

locally advanced
clinical trial
end stage renal disease
chronic kidney disease
randomized controlled trial
newly diagnosed
early stage
radiation therapy
rectal cancer
combination therapy
prognostic factors